Hofer S - Search Results

1

A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults.

Roth P, Hottinger AF, Hundsberger T, Läubli H, Schucht P, Reinert M, Mamot C, Roelcke U, Pesce G, Hofer S, Weller M. Roth P, et al. Among authors: hofer s. Swiss Med Wkly. 2020 Jun 18;150:w20256. doi: 10.4414/smw.2020.20256. eCollection 2020 Jun 1. Swiss Med Wkly. 2020. PMID: 32557428 Free article.

2

Dexamethasone treatment and plasma glucose levels: relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas.

Roelcke U, Blasberg RG, von Ammon K, Hofer S, Vontobel P, Maguire RP, Radü EW, Herrmann R, Leenders KL. Roelcke U, et al. Among authors: hofer s. J Nucl Med. 1998 May;39(5):879-84. J Nucl Med. 1998. PMID: 9591593 Free article.

3

[New aspects of interdisciplinary therapy for malignant gliomas in adults].

Hofer S, Roelcke U, Herrmann R. Hofer S, et al. Schweiz Med Wochenschr. 1999 Sep 18;129(37):1332-41. Schweiz Med Wochenschr. 1999. PMID: 10515007 Review. German.

4

Successful diffusible brachytherapy (dBT) of a progressive low-grade astrocytoma using the locally injected peptidic vector and somatostatin analogue [90Y]-DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC).

Hofer S, Eichhorn K, Freitag P, Reubi JC, Muller-Brand J, Maecke H, Merlo A. Hofer S, et al. Swiss Med Wkly. 2001 Nov 10;131(43-44):640-4. doi: 10.4414/smw.2001.09822. Swiss Med Wkly. 2001. PMID: 11835112 Free article.

5

Metabolic deactivation of low-grade glioma during chemotherapy.

Roelcke U, Wyss M, Bärtschi E, Hofer S. Roelcke U, et al. Among authors: hofer s. J Neurol. 2007 May;254(5):668-9. doi: 10.1007/s00415-006-0321-x. Epub 2007 Apr 6. J Neurol. 2007. PMID: 17410330 No abstract available.

6

Spatial heterogeneity of low-grade gliomas at the capillary level: a PET study on tumor blood flow and amino acid uptake.

Wyss MT, Hofer S, Hefti M, Bärtschi E, Uhlmann C, Treyer V, Roelcke U. Wyss MT, et al. Among authors: hofer s. J Nucl Med. 2007 Jul;48(7):1047-52. doi: 10.2967/jnumed.106.038489. Epub 2007 Jun 15. J Nucl Med. 2007. PMID: 17574979 Free article.

7

Evolution of glioblastoma.

Hofer S, Kollias S, Weller M. Hofer S, et al. Acta Oncol. 2009;48(4):630-1. doi: 10.1080/02841860802637799. Acta Oncol. 2009. PMID: 19107645 No abstract available.

8

Early metabolic responses in temozolomide treated low-grade glioma patients.

Wyss M, Hofer S, Bruehlmeier M, Hefti M, Uhlmann C, Bärtschi E, Buettner UW, Roelcke U. Wyss M, et al. Among authors: hofer s. J Neurooncol. 2009 Oct;95(1):87-93. doi: 10.1007/s11060-009-9896-2. Epub 2009 Apr 18. J Neurooncol. 2009. PMID: 19381442 Free article. Clinical Trial.

9

Bevacizumab does not increase the risk of remote relapse in malignant glioma.

Wick A, Dörner N, Schäfer N, Hofer S, Heiland S, Schemmer D, Platten M, Weller M, Bendszus M, Wick W. Wick A, et al. Among authors: hofer s. Ann Neurol. 2011 Mar;69(3):586-92. doi: 10.1002/ana.22336. Ann Neurol. 2011. PMID: 21446027

10

Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials.

Hofer S, Elandt K, Greil R, Hottinger AF, Huber U, Lemke D, Marosi C, Ochsenbein A, Pichler J, Roelcke U, Weder P, Zander T, Wick W, Weller M. Hofer S, et al. Acta Oncol. 2011 Jun;50(5):630-5. doi: 10.3109/0284186X.2011.572913. Epub 2011 Apr 18. Acta Oncol. 2011. PMID: 21495907

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,089 results

Search Page

Filters